Dr. Kristen Zeitler, a pharmacist and pharmacotherapy specialist at Tampa General Hospital, discusses basic information about how to properly dose antimicrobial agents in hospital patients. Dr. Zietler begins by discussing the role that ID clinical pharmacist play in hospitals. She then compares and contrasts the differences between pharmacokinetics (PK) and pharmacodynamics (PD). The principles of pharmacokinetics are then covered, with regard to absorption, distribution, metabolism, and elimination. Next, PK/PD concepts are explored, especially as it relates to Vancomycin. Lastly, adjustment of dosing in renal insufficiency or dialysis is explored.

Dr. Kristen Zeitler, a pharmacist and pharmacotherapy specialist at Tampa General Hospital, discusses basic information about how to properly dose antimicrobial agents in hospital patients. Dr. Zietler begins by discussing the role that ID clinical pharmacist play in hospitals. She then compares and contrasts the differences between pharmacokinetics (PK) and pharmacodynamics (PD). The principles of pharmacokinetics are then covered, with regard to absorption, distribution, metabolism, and elimination. Next, PK/PD concepts are explored, especially as it relates to Vancomycin. Lastly, adjustment of dosing in renal insufficiency or dialysis is explored.

Essentials of Antibiotic Dosing

Dr. Suzanne Silbert, Microbiology Director for Tampa General Hospital, presents this introductory talk on the basics of the microbiology lab. Dr. Silbert begins with an overview of clinical microbiology, and then reviews the basic classification standards for bacterial organisms, viruses and fungi. She then goes on to discuss culture cultivation techniques, including the use of liquid, solid, or semi-solid media. The speaker then covers identification systems for bacterial organisms, including MALDI-TOF, Disk-Diffusion, and molecular diagnostic techniques. A robust question and answer session concludes the session

Dr. Suzanne Silbert, Microbiology Director for Tampa General Hospital, presents this introductory talk on the basics of the microbiology lab. Dr. Silbert begins with an overview of clinical microbiology, and then reviews the basic classification standards for bacterial organisms, viruses and fungi. She then goes on to discuss culture cultivation techniques, including the use of liquid, solid, or semi-solid media. The speaker then covers identification systems for bacterial organisms, including MALDI-TOF, Disk-Diffusion, and molecular diagnostic techniques. A robust question and answer session concludes the session

Basic Principles of Microbiology

Dr. Jaraad Dattadeen, Infectious Diseases Senior Fellow at the Division of Infectious Diseases at the USF College of Medicine, discusses coronaviruses other than SARS-CoV2. Dr. Dattadeen begins by discussing the general classification of Coronaviruses as well as their microbiology. The speaker covers SARS CoV-1, MERS, as well as HCoV-OC43, HCoV-229, HCoV-NL63, and HCoV-HKU1. Each virus subtype is compared with SARS-CoV2. The intermediate hosts and reservoirs of select coronaviruses are also discussed.

Dr. Jaraad Dattadeen, Infectious Diseases Senior Fellow at the Division of Infectious Diseases at the USF College of Medicine, discusses coronaviruses other than SARS-CoV2. Dr. Dattadeen begins by discussing the general classification of Coronaviruses as well as their microbiology. The speaker covers SARS CoV-1, MERS, as well as HCoV-OC43, HCoV-229, HCoV-NL63, and HCoV-HKU1. Each virus subtype is compared with SARS-CoV2. The intermediate hosts and reservoirs of select coronaviruses are also discussed.

The “Other” Coronaviruses

Dr. Amro Elshereye, Infectious Diseases Fellow at the Morsani USF College of Medicine, explores the burgeoning field of artificial intelligence (AI) in medicine in this interactive presentation and faculty discussion. The speaker begins by discussing early warning systems such as Healthmap which utilize AI to predict developing outbreaks. Next, Dr Elshereye explains voice recognition technology in medicine, including AI-powered transcription systems such as Dragon Medical One. The discussion then moves on to generative transformer technology including ChatGPT, which could revolutionize many fields of health practice, including consultation, doctor-patient communication, and diagnostic interpretation. Lastly, Dr. Elshereye also explores the drawbacks of artificial intelligence and some of the grave predictions many technology thought leaders have made if guardrails are not put in place soon enough for AI.

Dr. Amro Elshereye, Infectious Diseases Fellow at the Morsani USF College of Medicine, explores the burgeoning field of artificial intelligence (AI) in medicine in this interactive presentation and faculty discussion. The speaker begins by discussing early warning systems such as Healthmap which utilize AI to predict developing outbreaks. Next, Dr Elshereye explains voice recognition technology in medicine, including AI-powered transcription systems such as Dragon Medical One. The discussion then moves on to generative transformer technology including ChatGPT, which could revolutionize many fields of health practice, including consultation, doctor-patient communication, and diagnostic interpretation. Lastly, Dr. Elshereye also explores the drawbacks of artificial intelligence and some of the grave predictions many technology thought leaders have made if guardrails are not put in place soon enough for AI.

Artificial Intelligence and Infectious Disease

Dr. William Greene, Infectious Diseases Fellow at the USF Morsani College Medicine, discusses biological weapons in this new podcast. After defining the concept of a bioweapon, Dr. Greene first discusses the extensive history of bioweapons, starting in ancient times, extending through the middle ages, through the world wars, and beyond the cold war to the present day. Next, Dr. Greene categorizes biologic terrorism agents by their CDC category, and discusses current bioterrorism threats. These include Anthrax, Plague, and Smallpox. Specific treatments to these infections are also discussed.

Dr. William Greene, Infectious Diseases Fellow at the USF Morsani College Medicine, discusses biological weapons in this new podcast. After defining the concept of a bioweapon, Dr. Greene first discusses the extensive history of bioweapons, starting in ancient times, extending through the middle ages, through the world wars, and beyond the cold war to the present day. Next, Dr. Greene categorizes biologic terrorism agents by their CDC category, and discusses current bioterrorism threats. These include Anthrax, Plague, and Smallpox. Specific treatments to these infections are also discussed.

Biological Warfare: Past, Present and Future

Dr Arun Sunny, infectious diseases fellow at the USF Morsani Division of Infectious Diseases, discusses three main publications that could change the practice habits of an Infectious Diseases specialist. The three publications involve: (1) The use of post-exposure doxycycline to prevent sexually transmitted infections; (2) The use of hydrocortisone for severe community acquired pneumonia; (3) Early lead extraction for infected implanted electronic devices; and (4) The effects of early sign-offs (discontinuation of care) of infectious diseases consultants. The presentation includes a lively discussion from participants on the merits and pitfalls of each of the presented studies.

Dr Arun Sunny, infectious diseases fellow at the USF Morsani Division of Infectious Diseases, discusses three main publications that could change the practice habits of an Infectious Diseases specialist. The three publications involve: (1) The use of post-exposure doxycycline to prevent sexually transmitted infections; (2) The use of hydrocortisone for severe community acquired pneumonia; (3) Early lead extraction for infected implanted electronic devices; and (4) The effects of early sign-offs (discontinuation of care) of infectious diseases consultants. The presentation includes a lively discussion from participants on the merits and pitfalls of each of the presented studies.

Notable Recent Studies that Could Affect Your Practice

Dr. Jacqueline Sherbuk, Assistant Professor of Medicine at the University of South Florida Morsani Division of Infectious Diseases, presents information on considerations for switching antiretroviral therapy in the HIV positive patient. Dr. Sherbuk begins by presenting the indications for switching therapy (pill burden, adverse effects, etc). Next, she explains various factors to consider when switching regimens, including prior ARV (antiretroviral) history, comorbidities, and so on. Next she covers the reasons for virologic failure, and how resistance assays are crucial to determining the best path forward if ARV agents need to be modified. Dr. Sherbuk then relates the basic principles of choosing a new ARV regimen. Lastly, the speaker discusses several case based examples of switching therapy with explanation of the rationale and best practice approaches in doing so.

Dr. Jacqueline Sherbuk, Assistant Professor of Medicine at the University of South Florida Morsani Division of Infectious Diseases, presents information on considerations for switching antiretroviral therapy in the HIV positive patient. Dr. Sherbuk begins by presenting the indications for switching therapy (pill burden, adverse effects, etc). Next, she explains various factors to consider when switching regimens, including prior ARV (antiretroviral) history, comorbidities, and so on. Next she covers the reasons for virologic failure, and how resistance assays are crucial to determining the best path forward if ARV agents need to be modified. Dr. Sherbuk then relates the basic principles of choosing a new ARV regimen. Lastly, the speaker discusses several case based examples of switching therapy with explanation of the rationale and best practice approaches in doing so.

Switching Antiretroviral Therapy

Dr. Todd Wills, Professor of Medicine with the Morsani College of Medicine at the University of South Florida, reviews the unique complications and issues that can occur in the elderly HIV patient. Dr. Wills begins by reviewing the epidemiology of HIV by age group, including the fact that the HIV positive population is growing older with time. Dr. Wills also discusses issues regarding polypharmacy and medication tolerability in the older patient. Next, the speaker relates how the high prevalence of chronic diseases affect the HIV positive patient’s prognosis. HIV positive elderly patients can suffer not just from frailty, but from cardiovascular disease, diabetes, osteoporosis, and cancer. Dementia can also affect an elderly HIV paitent’s overall wellness and compliance with antiviral therapy. Dr. Wills also covers the assessment of bone density in elderly HIV positive patients. Lastly, Dr. Wills discusses HIV positive patient life expectancy in the modern age of antiretroviral therapy.

Dr. Todd Wills, Professor of Medicine with the Morsani College of Medicine at the University of South Florida, reviews the unique complications and issues that can occur in the elderly HIV patient. Dr. Wills begins by reviewing the epidemiology of HIV by age group, including the fact that the HIV positive population is growing older with time. Dr. Wills also discusses issues regarding polypharmacy and medication tolerability in the older patient. Next, the speaker relates how the high prevalence of chronic diseases affect the HIV positive patient’s prognosis. HIV positive elderly patients can suffer not just from frailty, but from cardiovascular disease, diabetes, osteoporosis, and cancer. Dementia can also affect an elderly HIV paitent’s overall wellness and compliance with antiviral therapy. Dr. Wills also covers the assessment of bone density in elderly HIV positive patients. Lastly, Dr. Wills discusses HIV positive patient life expectancy in the modern age of antiretroviral therapy.

HIV in the Elderly

Dr. Jesus Diaz, Infectious Diseases Fellow at the University of South Florida Division of Infectious Diseases, reviews the burgeoning anti-infective technology known as bacteriophage therapy. Bacteriophages are virions that have strong antibacterial properties. Dr. Diaz first reviews the history of bacteriophage therapy. He then reviews the morphology and anatomy of bacteriophages. Dr Diaz then differentiates the lysogenic versus lytic cycle and explains the role of bacterial transduction. The speaker then reviews the specifics of phage therapy. Lastly, Dr Diaz covers a few examples of the use of bacteriophage therapy in clinical practice.

Dr. Jesus Diaz, Infectious Diseases Fellow at the University of South Florida Division of Infectious Diseases, reviews the burgeoning anti-infective technology known as bacteriophage therapy. Bacteriophages are virions that have strong antibacterial properties. Dr. Diaz first reviews the history of bacteriophage therapy. He then reviews the morphology and anatomy of bacteriophages. Dr Diaz then differentiates the lysogenic versus lytic cycle and explains the role of bacterial transduction. The speaker then reviews the specifics of phage therapy. Lastly, Dr Diaz covers a few examples of the use of bacteriophage therapy in clinical practice.

Advances in Bacteriophage Therapy

Dr. Shylah Moore-Pardo, infectious diseases clinician at the James A Haley Veterans Hospital, reviews antiretroviral initiation in HIV positive patients. Dr. Pardo begins by discussing the interpretation of HIV test results. Next, she highlights several unique positive test scenarios.  Dr. Pardo then reviews the characteristic serological patterns of acute HIV infection. The speaker then goes on to describe essential components of the initial HIV positive patient encounter. She then relates recommended test and treat strategies compatible with current guidelines. Lastly, she covers the next steps in management for future patient visits.

Dr. Shylah Moore-Pardo, infectious diseases clinician at the James A Haley Veterans Hospital, reviews antiretroviral initiation in HIV positive patients. Dr. Pardo begins by discussing the interpretation of HIV test results. Next, she highlights several unique positive test scenarios. Dr. Pardo then reviews the characteristic serological patterns of acute HIV infection. The speaker then goes on to describe essential components of the initial HIV positive patient encounter. She then relates recommended test and treat strategies compatible with current guidelines. Lastly, she covers the next steps in management for future patient visits.

HIV Test and Treat:  Initiating Antiretroviral Therapy

Excellent content ...but some episodes I can’t play especially the episodes in the 2 Nd half of 2019 - please fix thanks

Excellent

USF Health’s IDPodcasts

Dr. Addisu looks at inflammation, and how it can be used as a marker of certain physiologic processes such as infection. He then differentiates the different types of acute phase reactants that are well-described markers of inflammation. He focuses upon the two most widely used markers, the erythrocyte sedimentation rate (ESR) and the C-reactive protein, and compares and contrasts the two. Next, he discusses the procalcitinin and the white blood cell (WBC) count. He closes by contrasting the activity of different inflammatory markers (IM’s) in infectious syndromes such as sepsis and endocarditis, and briefly touches upon several novel assays which show promise as IM’s of the future.

Dr. Addisu looks at inflammation, and how it can be used as a marker of certain physiologic processes such as infection. He then differentiates the different types of acute phase reactants that are well-described markers of inflammation. He focuses upon the two most widely used markers, the erythrocyte sedimentation rate (ESR) and the C-reactive protein, and compares and contrasts the two. Next, he discusses the procalcitinin and the white blood cell (WBC) count. He closes by contrasting the activity of different inflammatory markers (IM’s) in infectious syndromes such as sepsis and endocarditis, and briefly touches upon several novel assays which show promise as IM’s of the future.

Inflammatory Markers as A Decision Support Tool in Infectious Diseases

Dr. Ward reviews basic concepts about antimicrobial drug interactions. She begins by discussing the basic classification scheme, and then moves on to discuss several commonly recognized adverse drug interactions, as well as some that are commonly forgotten. She also reviews the topic of QT drug prolongation, the interaction between daptomycin and statins, as well as the most relevant azole interactions. She reviews serotonergic interactions, especially with linezolid. Lastly, she reviews the interaction between valproic acid and carbapenems. And the best reference sources for reviewing adverse drug interactions with antimicrobials are also discussed.

Dr. Ward reviews basic concepts about antimicrobial drug interactions. She begins by discussing the basic classification scheme, and then moves on to discuss several commonly recognized adverse drug interactions, as well as some that are commonly forgotten. She also reviews the topic of QT drug prolongation, the interaction between daptomycin and statins, as well as the most relevant azole interactions. She reviews serotonergic interactions, especially with linezolid. Lastly, she reviews the interaction between valproic acid and carbapenems. And the best reference sources for reviewing adverse drug interactions with antimicrobials are also discussed.

Antimicrobial Drug Interactions

Dr. Jamie Morano reviews sexually transmitted infections among MSMs (men who have sex with men). She discusses current sexually transmitted infection screening, testing, and treatment guidelines for the group. The use of preexposure prophylaxis for MSMs is also introduced, and includes information on eligibility and an implementation strategy for patients. Lastly, Dr. Morano touches upon HIV screening and rapid treatment approaches to care.

Dr. Jamie Morano reviews sexually transmitted infections among MSMs (men who have sex with men). She discusses current sexually transmitted infection screening, testing, and treatment guidelines for the group. The use of preexposure prophylaxis for MSMs is also introduced, and includes information on eligibility and an implementation strategy for patients. Lastly, Dr. Morano touches upon HIV screening and rapid treatment approaches to care.

Understanding Military MSMs: STI, PrEP, and ID Care in your Medical Practice

Dr. Jamie Morano reviews pre-exposure prophylaxis for high-risk HIV-related exposures. She provides justification for its efficacy, its criteria for use, as well as its use in selective patient groups (e.g., heterosexuals, MSMs, serodiscordant couples, substance users). She reviews the CDC guidelines for PREP and reviews a Florida Department of Health PREP action tool kit. Presented in affiliation with the Florida Department of Health. Part IV of a four-part series.

Dr. Jamie Morano reviews pre-exposure prophylaxis for high-risk HIV-related exposures. She provides justification for its efficacy, its criteria for use, as well as its use in selective patient groups (e.g., heterosexuals, MSMs, serodiscordant couples, substance users). She reviews the CDC guidelines for PREP and reviews a Florida Department of Health PREP action tool kit. Presented in affiliation with the Florida Department of Health. Part IV of a four-part series.

HIV Boot Camp IV: PREP for All Occasions

Dr. Baluch reviews the topic of invasive fungal infections (IFIs) in individuals who undergo hematopoietic stem cell transplantation (HCST). The author begins by reviewing risk factors for IFIs. She then discusses what constitutes an IFI. She differentiates infections caused by yeasts versus those due to molds, and discusses the assessment and management of invasive candida disease. Next, Dr. Baluch discusses non candida molds, including aspergillus, fusarium, and Mucor as well as atypical pathogens such as Pneumocystis. She closes with a discussion of antifungal therapy and what constitutes the ideal fungal agent.

Dr. Baluch reviews the topic of invasive fungal infections (IFIs) in individuals who undergo hematopoietic stem cell transplantation (HCST). The author begins by reviewing risk factors for IFIs. She then discusses what constitutes an IFI. She differentiates infections caused by yeasts versus those due to molds, and discusses the assessment and management of invasive candida disease. Next, Dr. Baluch discusses non candida molds, including aspergillus, fusarium, and Mucor as well as atypical pathogens such as Pneumocystis. She closes with a discussion of antifungal therapy and what constitutes the ideal fungal agent.

Invasive Fungal Infections in the Immunosuppressed

Dr. Jamie Morano discusses the U equals U campaign to reduce the transmissibility of human immunodeficiency virus infections by ensuring that individuals at high risk for transmission receive treatment. This has been proven to have the greatest impact in reducing to transmission of the virus to both monogamous and non-monogamous partners. This is part III in a four part series, entitled, HIV Boot Camp

Dr. Jamie Morano discusses the U equals U campaign to reduce the transmissibility of human immunodeficiency virus infections by ensuring that individuals at high risk for transmission receive treatment. This has been proven to have the greatest impact in reducing to transmission of the virus to both monogamous and non-monogamous partners. This is part III in a four part series, entitled, HIV Boot Camp

HIV Boot Camp III: Undetectability = Untransmissability

Dr. Sandin provides a general overview of identification techniques for Mycobacterial organisms. He discusses and outlines classification systems for the Mycobacteria that are human pathogens. He then discusses laboratory stains that are useful in identifying Mycobacteria and reviews other diagnostic methods which have become essential to Mycobacterial species identification, including the various nucleic amplification-based methods. Various pathology pearls of Mycobacterial identification are also mentioned. Lastly, he discusses two clinical cases involving acid fast organisms.

Dr. Sandin provides a general overview of identification techniques for Mycobacterial organisms. He discusses and outlines classification systems for the Mycobacteria that are human pathogens. He then discusses laboratory stains that are useful in identifying Mycobacteria and reviews other diagnostic methods which have become essential to Mycobacterial species identification, including the various nucleic amplification-based methods. Various pathology pearls of Mycobacterial identification are also mentioned. Lastly, he discusses two clinical cases involving acid fast organisms.

Medical and Diagnostic Mycobacteriology of Importance to the Clinician and Pathologist

Dr. Kumar relates some of the basic concepts behind medical study design, enabling the listener to utilize simple tools to be able to review the medical literature with a critical eye. He also addresses the question, “What constitutes BEST evidence?” Dr. Kumar also reviews basic statistical concepts, including prevalence/pre-test probability, sensitivity and specificity, negative and positive predictive value, likelihood ratios, and post-test probability. The talk is a very easily understandable and relatable discussion of evidence-based medicine.

Dr. Kumar relates some of the basic concepts behind medical study design, enabling the listener to utilize simple tools to be able to review the medical literature with a critical eye. He also addresses the question, “What constitutes BEST evidence?” Dr. Kumar also reviews basic statistical concepts, including prevalence/pre-test probability, sensitivity and specificity, negative and positive predictive value, likelihood ratios, and post-test probability. The talk is a very easily understandable and relatable discussion of evidence-based medicine.

Fundamental Concepts of Study Design

Dr. Daniel Haight, Associate Professor at the USF College of Medicine, and Vice President of Community Health with Lakeland Regional Health, presents a primer on ways to foster and enhance antibiotic stewardship efforts in your hospital or health care system. Presented to the northern Iceland clinics and hospital in Akureyri, Iceland in April, 2018.  The presentation features English narration with Icelandic/English slide content. Part of IDPodcast’s international podcast series.

Dr. Daniel Haight, Associate Professor at the USF College of Medicine, and Vice President of Community Health with Lakeland Regional Health, presents a primer on ways to foster and enhance antibiotic stewardship efforts in your hospital or health care system. Presented to the northern Iceland clinics and hospital in Akureyri, Iceland in April, 2018.  The presentation features English narration with Icelandic/English slide content. Part of IDPodcast’s international podcast series.

Antibiotic Stewardship and Superbugs

Dr. Chugtai reviews the family of Viral Hemorrhagic Fevers. He starts out by discussing transmission factors and major common symptoms for the class of disorders. He then covers the Bunyaviridae, including Hantavirus Pulmonary Syndrome and Rift Valley Fever. Dr. Chugtai then mentions the hemorrhagic fevers, including Ebola and Marburg viruses. Other hemorrhagic fevers dicussed includes Nipah virus disease and Hendra virus disease. Lastly, he discusses the flaviviruses, including Tick-borne encephalitis (TBE).

Dr. Chugtai reviews the family of Viral Hemorrhagic Fevers. He starts out by discussing transmission factors and major common symptoms for the class of disorders. He then covers the Bunyaviridae, including Hantavirus Pulmonary Syndrome and Rift Valley Fever. Dr. Chugtai then mentions the hemorrhagic fevers, including Ebola and Marburg viruses. Other hemorrhagic fevers dicussed includes Nipah virus disease and Hendra virus disease. Lastly, he discusses the flaviviruses, including Tick-borne encephalitis (TBE).

Viral Hemorrhagic Fevers

Dr. Jamie Morano reviews updated information regarding the current epidemiology, prevalence, pre-treatment assessment, and therapeutic options for the management of this common viral pathogen.  She begins by discussing current worldwide epidemiology.  She breaks down U.S. trends both regionally and state by state. She elaborates on the significance of specific genotypes in hepatitis treatment and in disease complications. Testing guidelines are also reviewed. Next, Dr. Morano reviews current antiviral therapies and breaks them down by agent and co-formulation. Lastly, she discusses pretreatment options for patients who fail initial therapy.

Hepatitis C Boot Camp 1: Pathogenesis, Epidemiology, and Treatment Guidelines

Dr. Jamie Morano reviews HIV infection. She starts out by presenting up to date statistics about the current epidemiology of HIV infection across the US and Florida. She then goes on to discuss the HIV life cycle, and how various antiretroviral treatments appear to interact with the virus at different points of the viral reproductive process. HIV resistance mechanisms are also addressed. Lastly, she shares her recommendations on strategies useful to selecting an ideal antiretroviral regimen for an HIV positive patient.

Dr. Jamie Morano reviews HIV infection. She starts out by presenting up to date statistics about the current epidemiology of HIV infection across the US and Florida. She then goes on to discuss the HIV life cycle, and how various antiretroviral treatments appear to interact with the virus at different points of the viral reproductive process. HIV resistance mechanisms are also addressed. Lastly, she shares her recommendations on strategies useful to selecting an ideal antiretroviral regimen for an HIV positive patient.

Meeting the Resistance Movement, Up Close and Personal: Understanding HIV Resistance

Drawing inspiration from sessions she attended at IDWeek 2017, Dr. Fredenrich discusses the sociological aspects of antimicrobial stewardship, including the strategies that can be employed to change the prescribing habits of frontline clinicians. She discusses the social determinants of antibiotic prescribing, such as clinician-clinician relationships, patient expectations, fear of adverse consequences, and other pressures. Dr. Fredenrich also discusses everyday barriers, such as trust-building and knowledge sharing that can improve the overall success of an antibiotic stewardship program.

Drawing inspiration from sessions she attended at IDWeek 2017, Dr. Fredenrich discusses the sociological aspects of antimicrobial stewardship, including the strategies that can be employed to change the prescribing habits of frontline clinicians. She discusses the social determinants of antibiotic prescribing, such as clinician-clinician relationships, patient expectations, fear of adverse consequences, and other pressures. Dr. Fredenrich also discusses everyday barriers, such as trust-building and knowledge sharing that can improve the overall success of an antibiotic stewardship program.

Social Stewardship

Have you ever taken an antibiotic “just-in-case” there might be an infection and thought antibiotics are “risk-free” drugs? Prescribing antibiotics “just-in-case” carries the risk of creating superbugs that can be resistant to every antibiotic. The overuse of antibiotics in humans and animals today means untreatable infections tomorrow. Dr. Debbie Goff pharmacist, global antibiotic steward and advocate describes how consumers and patients need to become antibiotic stewards. It is no longer just up to medical professionals. Our children’s children depend on getting everyone engaged in antibiotic stewardship. Debbie Goff Pharm.D. is an internationally renowned infectious diseases clinical pharmacist who works hand in hand with physicians and pharmacists in hospitals across six continents advocating for the responsible use of antibiotics through antibiotic stewardship. From a TedRx Columbus talk originally presented in December, 2016. Reposted with permission of the author. An IDPodcasts.net guest presentation available on our web site exclusively.

Have you ever taken an antibiotic “just-in-case” there might be an infection and thought antibiotics are “risk-free” drugs? Prescribing antibiotics “just-in-case” carries the risk of creating superbugs that can be resistant to every antibiotic. The overuse of antibiotics in humans and animals today means untreatable infections tomorrow. Dr. Debbie Goff pharmacist, global antibiotic steward and advocate describes how consumers and patients need to become antibiotic stewards. It is no longer just up to medical professionals. Our children’s children depend on getting everyone engaged in antibiotic stewardship. Debbie Goff Pharm.D. is an internationally renowned infectious diseases clinical pharmacist who works hand in hand with physicians and pharmacists in hospitals across six continents advocating for the responsible use of antibiotics through antibiotic stewardship. From a TedRx Columbus talk originally presented in December, 2016. Reposted with permission of the author. An <a href="http://IDPodcasts.net" rel="nofollow" target="_blank">IDPodcasts.net</a> guest presentation available on our web site exclusively.

Antibiotics: Just In Case

Dr. Pardo discusses the natural association of infections and natural disasters. She reflects upon events of recent history, including the 2017 hurricanes affecting Puerto Rico, the Caribbean, and the southeastern US, outbreaks after earthquakes, tornados and tsunamis. She also touches upon vector-borne diseases. Lastly, she discusses ways that infectious diseases can be prevented after natural disasters occur.

Dr. Pardo discusses the natural association of infections and natural disasters. She reflects upon events of recent history, including the 2017 hurricanes affecting Puerto Rico, the Caribbean, and the southeastern US, outbreaks after earthquakes, tornados and tsunamis. She also touches upon vector-borne diseases. Lastly, she discusses ways that infectious diseases can be prevented after natural disasters occur.

Infections After Natural Disasters

Dr. Pasikhova discusses the history of the Pneumocystis pathogen, its epidemiology, and how it is transmitted to patients. She also discusses the pathophysiology of the infection in the context of the immunocompromised cancer patient. The role of steroids in the aquisition of PJP infection is touched upon. Lastly, Dr. Pasikhova describes prophylaxis against Pneumocystis, including specific agents and their usual doses.

Dr. Pasikhova discusses the history of the Pneumocystis pathogen, its epidemiology, and how it is transmitted to patients. She also discusses the pathophysiology of the infection in the context of the immunocompromised cancer patient. The role of steroids in the aquisition of PJP infection is touched upon. Lastly, Dr. Pasikhova describes prophylaxis against Pneumocystis, including specific agents and their usual doses.

Pneumocystis Jirovecii Pneumonia (PCP): The Non-HIV-infected Patients

Dr. Klinkova reviews CSF device-associated infections, an important potential source of morbidity for neurosurgical patients. She first discusses risk factors, and then transitions to discuss the pathogenesis and microbiology of shunt infections. Next, she reviews the typical clinical presentation of patients who present with the syndrome, and then discusses diagnostic pearls for identifying patients with CSF device infections. She then reviews the management of these patients including the principles of antibiotic selection. Lastly, Dr. Klinkova covers CSF device-associated infection prophylaxis.

Dr. Klinkova reviews CSF device-associated infections, an important potential source of morbidity for neurosurgical patients. She first discusses risk factors, and then transitions to discuss the pathogenesis and microbiology of shunt infections. Next, she reviews the typical clinical presentation of patients who present with the syndrome, and then discusses diagnostic pearls for identifying patients with CSF device infections. She then reviews the management of these patients including the principles of antibiotic selection. Lastly, Dr. Klinkova covers CSF device-associated infection prophylaxis.

Infections of CSF Shunts and Other CSF Devices

Dr. Syed focuses on the diagnostic sign of fever and the ways that non-infectious factors can induce the febrile response. Dr. Syed covers neoplastic fever, central fever, neurogenic fever, autonomic dysreflexia, drug fever, periodic fever, Familial Mediterranean Fever, TRAPS, and some other less common syndromes. Dr Syed also touches on the history of how the “normal” temperature for average individuals was calculated.

Dr. Syed focuses on the diagnostic sign of fever and the ways that non-infectious factors can induce the febrile response. Dr. Syed covers neoplastic fever, central fever, neurogenic fever, autonomic dysreflexia, drug fever, periodic fever, Familial Mediterranean Fever, TRAPS, and some other less common syndromes. Dr Syed also touches on the history of how the “normal” temperature for average individuals was calculated.

Infectious Diseases Mimics and Fever

In the midst of the 2019-2020 Coronavirus pandemic, the concept of “zoonotic” infections–and how previously unknown diseases can transfer from the animal kingdom to humans–is facing more attention than ever.  In this spirit, we present this encore lecture originally presented by Dr. Mindy Sampson in 2018. Dr. Sampson looks at the underlying features of a zoonotic disease. She then discusses how increasing globalization has interwoven with zoonoses to produce widespread outbreaks of Yellow fever, SARS, Nipah Virus, and Ebola virus disease. Among the most notable of the Zoonotic diseases of the last several decades is HIV, and she presents a fascinating review of how this retrovirus originated from primates and then spread around the world in only a relatively short period of time.  She also recounts the 1918 Spanish Influenza pandemic and the factors that led it to spread around the world in just a few months.

In the midst of the 2019-2020 Coronavirus pandemic, the concept of “zoonotic” infections–and how previously unknown diseases can transfer from the animal kingdom to humans–is facing more attention than ever.  In this spirit, we present this encore lecture originally presented by Dr. Mindy Sampson in 2018. Dr. Sampson looks at the underlying features of a zoonotic disease. She then discusses how increasing globalization has interwoven with zoonoses to produce widespread outbreaks of Yellow fever, SARS, Nipah Virus, and Ebola virus disease. Among the most notable of the Zoonotic diseases of the last several decades is HIV, and she presents a fascinating review of how this retrovirus originated from primates and then spread around the world in only a relatively short period of time.  She also recounts the 1918 Spanish Influenza pandemic and the factors that led it to spread around the world in just a few months.

Zoonoses and Globalization

Dr. Kraitman reviews the management and treatment of infections occurring in the pregnant female. He initially reviews medication pregnancy risk categories, and then through interactive case review, goes over several examples where antimicrobial agents are used that are contraindicated in pregnancy. He reviews interactions relevant to HIV/AIDS, AIDS associated opportunistic infections, Tuberculosis, Malaria, CMV, Syphilis, and Listeria. He closes by providing information on useful reference resources for managing infections in pregnancy.

Dr. Kraitman reviews the management and treatment of infections occurring in the pregnant female. He initially reviews medication pregnancy risk categories, and then through interactive case review, goes over several examples where antimicrobial agents are used that are contraindicated in pregnancy. He reviews interactions relevant to HIV/AIDS, AIDS associated opportunistic infections, Tuberculosis, Malaria, CMV, Syphilis, and Listeria. He closes by providing information on useful reference resources for managing infections in pregnancy.

Infections in Pregnancy

The best self improvement podcast episodes. From improving productivity, to finding purpose in your life to what constitutes freedom, this topic is on anything and everything that can help people to improve their lives. Add episodes you're interested into your queue below!

Best Episodes on Self Improvement, Growth & Development

The best podcasts on investing. For anyone interested in the stories in the investing industry, whether it's an interview with Ray Dalio or Ed Thorp to the writer of The Big Short. This topic includes the most fascinating stories from all the best investors. Add episodes you're interested into your queue below!